<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 273 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page272.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=273">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 273 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 273</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=273"><img src="../thumb/273.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>236 / 2020-04                                                             Anti-Microbials - 18.2
   funct. impairm., monit.theophyll./carbamazepine ser. conc., other   H.pylori eradicat: 500 mg 2xdly.in combinat. with appropr.antibiot.&   Indications: Adults & childr.over 45 kg: Suscept. U&LRT, un-
   macrolide meds./lincomycin & clindamycin cross-sens., superinfect.  an acid low.agent x 7-10 days.  complic.skin & soft tiss. infects.& uncomplic.genit.chlamydia tra-
   with longt. use, discont.ther.in case of pseudomembr.colit., myasth.  HIV pts.with atypic.Mycobact.infects: 500 mg 2xdly. Cont.as long   chomat. infects.
   grav.sympt.exacerbat., concom. triazolobenzodiazepin./ meds.induc.  as clinic.& microbiologic. benef.demonstrat. Decr.effic.noted if treatm.   Childr.over 45 kg: Suscept.pharyngit./tonsillit.& otit. media
   cytochrome CYP3A4 enzym., community/hospit.acquir.pneum., skin   exceeds 12 wks. Use in conjunct.with other antimycobact.agents  (S4) TABS, A40/20.1.1/0334
   & soft tissue infects.caus.by S aureus/S pyogen., diab.mellit., monit.  Contraindications: Concom.admin.astemizole /cisapride/pimozide   707852-001: 500 mg, 3, R125,85
   INR & prothromb., longt. ther./high dos.immunocompromis.pts., poss.   & terfenadine., porphyr., concom.ritonavir with dos.great.than 1 g/  Dosage: Tabs.not suit.for childr.und.45 kgs.
   digox.toxic., admin.zidovudine 4 hrs.apart, incr. incid. of uveitis.with   day., safety in pregn.& lactat.not est.  Adults & childr.over 45 kg: 500 mg once dly x3 days. Dos.regime
   concom.rifabutin & rifampic. than rifabutin alone, quinidine/disop-  Side effects: Thrombocytopen., leucopen., neutropen., infect., fev.,   over 5 days: 500 mg on day 1, then 250 mg dly.on days 2-5.
   yramide ser lev./ECG monit., poss.colchicine toxic.somet.fatal esp.   chills, cough, hoarsen., lower back/side pain, painf./diffic.urinat., QT   Chlamyd.trachomat: Adults: 1 g as sngl.dos.
   elderly with ren.insuff., avoid midazolam oral treatm.& monit.if IV ad-  prolongat./torsades de pointes./ventric. tachycard. & arrhythm., CNS   Contraindications: Sens.to macrolide antibiot., concom.ergot.
   min.as well as other benzodiazepin.metabol.by CYP3A4, limit.treatm.  eff.incl.hallucinat., nightmares, vertigo, tinnit., disorientat., deperson-  derivat., liv.funct.impairm., safety & effic.in pregn./lactat.& childr.
   to 14 days if creatin.clear.&lt;30 ml/min., monit.ser. conc. of concom.  alisat., confus., hear.loss, convuls., hypoglycaem., GI disturbs.incl.  und.1 yr not est.
   digox./ theophyll./ carbamazepine & meds.metabol.by cytochrome   abnorm.taste sensat., dyspeps., glossit., stomatit., oral candidias.,   Side effects: Neutropen., palpit.& arrythm.incl. ventric.tachycard.,
   P450 syst., concom. tolterodine, monit.valproate/phenytoin ser. lev.  pseudomembran.colit., hepatotoxic., hepat.dysfunct., pancreatit.,   chest pain, CNS effs., hear. loss., convuls., asthen., parathes., GI dis-
   Drug interactions: QT prolong.& card.dysrhythm. with astemizole/  skin reacts.incl. Stev. John.syndr.& tox.epiderm.necrolysis, hypers-  turbs., malaena, interstit.nephrit., ac.ren.fail., vaginit., trans. elev.liv.
   cisapride & pimozide, poss.ergot toxic.with ergotamine or dihydro-  ens. reacts.incl.anaphylax., tongue & tooth discol.  enzymes, cholestat.jaund., hepatit., erythema multiforme, Stev.-John.
   ergotamine, incr. rhabdomyolys.risk with HMG-CoA reduct.inhibits.,   Special precautions: Imp.hepat.funct.with sev. ren.impairm., sev.  syndr., tox. epiderm.necrolys., allerg.reacts.incl.anaphylax., superinfect.
   rifabutin & rifampicin decr.ser.conc., theophylline /carbamazepine   ren.funct., rhabdomyolys. report. with concom.HMGCoA reduct.  Special precautions: Ren.funct.impairm., prolong. observat.&
   AUC incr., potent.warfar.eff., poss. signif. hypoglycaem.with oral   symptomat.treatm.of allerg. reacts.as sympt.have recurr.despite dis-
   hypoglycaem. agents &/ insul., digox.ser.conc.elev., zidovudine ser.  inhibit., monit.theophyll.ser.conc.recomm., other macrolide meds./  cont., poss. pseudomembr.colit., admin.1 hr.bef.or 2 hrs. aft.antacids.,
                                lincomycin & clindamycin cross-resist., monit.prothrom.time with
   conc.decr., hypotens.bradydysrhythm./lact. acidos.with verapamil,   monit.prothromb.time with concom. warfar.
   incr.PDE5 inhibit.expos., metabol.inhibit.by ritonavir & poss.other   anticoags., monit. digox.ser.conc., monit.ser.lev.of concom. meds.   Drug interactions: Antacids decr.peak ser. conc., ac.ergot.toxic.with
                                metabol.by cytochrome P450 enzyme., admin. zidovudine 4 hrs.
   HIV-protease inhibit.& non-nucleoside reverse transcript. inhibit., incr   ergot alkaloids, ser. digox.conc.poss.incr.
   atazanavir/saquinavir plasma conc., incr.itraconazole plasma lev.&   apart, excret.in human breast milk., safety & effic.in combinat.with
   vice versa, reduc.eff.with CYP3A4 induc.e.g. rifampicin/ phentyoin/  proton-pump inhibit.other than omeprazole not est., discont.if signs   VARIMAX, (Ascendis) MDI [P/S]
   carbamazepine/phenobarb./St John’s Wort, poss.incr.mean steady-  of hepat.dysfunct.develop, hypoglycaem.report.in some pts.on oral   Azithromycin.(as dihydrate)
   state minim.conc.& AUC with fluconazole, incr midazolam AUC esp.   hypoglycaem. /insul., incr.uveitis incid.with concom. rifabutin & ri-  Indications: Adults & childr.over 45 kg: Mild-mod. sev.LRTI incl.
   oral, ser.lev.of meds.metabol.by cytochrome P450 syst. poss.elev.,   fampicin.than rifabutin alone,  bronchit., uncomplic.skin & soft tiss.infects.by suscept.organ., sinusit,
   incr.in mean steady-state omeprazole conc.& AUC.  Drug interactions: Rifabutin & rifampicin decr. ser. conc., theophyl-  uncomplic. genit. chlamydia trachomat.infects.
                                line area under plasma curve incr., QT-prolong.& card.arrhythm.incl.
   KLARITHRAN, Ranbaxy [P/S]    ventricul. tachycard./ fibrillat.& torsade de pointes with astemizole/  (S4) CAPS, 36/20.1.1/0164
                                                              717496-001: 250 mg, 6, R121,61
   Clarithromycin.              cisapraide/pimozide & terfenadine, potent. warfarin eff., elev.digox.  Dosage: Admin.as.sngl.dly.dos.of 2 caps 1 hr bef. or 2 hrs.aft.meals.
   Indications: U&LRTI, ac.otit.media, skin & soft tiss.infects., H. pylori   ser.conc., poss. elev.ser.lev.of meds.metabol.by the cytochrome   Adults & childr.over 45 kg: 1.5 g admin.as 500 mg dly x3 days.
   eradicat.in combinat.with a proton-pump inhibit.& another antibiot.  P450 syst., rhabdomyolys.reported with HMGCoA reduct.inhibits.,   Chlamyd.trachomat: Adults: 1 g as sngl.dos.
   to decr. recurr.of duod.ulc.  zidovudine ser.conc.decr., metabol. inhibit.by ritonavir & poss other   Contraindications: Hypersens.to macrolide antibiot., concom.ergot.
   (S4) TABS, 37/20.1.1/0437    HIV-protease inhibit.& non-nucleoside reverse transcript. inhibit.  derivat., hepat.impairm., safety & effic.in pregn.& lactat.& childr.und.1
   704464-002: 500 mg, 10, R94,84                             yr not est., formulat.not suit.for childr. &lt;45kg
   704464-001: 500 mg, 14, R132,76  PURMYCIN, (Aspen Pharmacare: Pharma) Pharmacare [P/S]
   (S4) SUSP, 38/20.1.1/0174, 0175  Erythromycin estolate equiv.to erythromycin.  Side effects: GI disturbs., melaena, elev.liv. enzymes, cholestat.
                                                              jaund., revers.hear.impairm., reduc. neutrophil.count, headache,
   704649-001: 125 mg/5 ml, 60 ml, R95,80  Indications: RTI’s/UTI’s/GI infects./skin & soft tiss.infects., scarlet
   704650-001: 250 mg/5 ml, 60 ml, R176,24  fev., tetanus, early syphil., gonococcal arthrit., dermatit.syndr., men-  vertigo, chest pain, palpit., CNS effs., nephrit., vaginit., allerg. reacts.
   Dosage:                      ingit., bacteraem., prophylact.use in rheumat.fev.& bact. endocardit.  incl.anaphylax., superinfect.
   Adults: 250-500 mg 2xdly.    (S4) CAPS, [P/S] L/20.1.1/145.  Warnings and special precautions: As recurr. allerg. react
   H.pylori eradicat: 500 mg 2xdly.in combinat. with appropr antibiot   758388-012: 250 mg, 100, R121,45  sympts.incl angioed.& anaphalax. report. long per.of observ.&
   & acid low.agent x7-10 days. Safety & effic.with proton-pump inhibit.  758388-020: 250 mg, 500, R607,27  treatm.req., poss. pseudomembr.colit.& super infect., ren.funct.
   other than  omeprazole not est.  Dosage: Admin.eith.1 hr.bef./ 3 hrs. aft.meals. Usual adult dos:   impairm., admin.1 hr.bef.or 2 hrs.aft.antacids., if monit.concom.cy-
   HIV pts.with atypic.Mycobact.infects: 500 mg 2xdly. Cont.as   1-2 g dly.giv. 6 hrly depend.on sev.of infect. May be doubl.in sev.in-  clospor lev.& adjust.dos.accord., concom. digox., monit.prothromb.
   long as clinic.& microbiologic. benef.demonstrat. Decr.effic.noted if   fects. Streptococc.infects: 250-500 mg 6 hrly for 10 days prevent.  time with concom. warfar.
   treatm. exceeds 12 wks.      rheumat.fev./ glomerulonephrit. occur. in group A beta-haemolyt.  Drug interactions: Ergot.theoretic.poss.with concom. ergot de-
   Childr: Usual durat: 5-10 days. Admin.2xdly.  Streptococc. infects.  riv., relat.macrolide antibiot.may interfer.with cyclospor. metabol./
   8-11 kg (1-2 yrs): 62,5 mg. 12-19 kg (2-4 yrs): 125 mg. 20-29 kg   Bact.endocardit.prophylax.follow. dent./ oropharyng.proced:   imp.digox. metabol.
   (4-8 yrs): 187,5 mg. 30-40 kg (8-12 yrs): 250 mg.  1 g 1,5-2 hrs.bef. proced. foll.by 500 mg 6 hrly.x 8 dos.  ZITHROGEN, (Mylan) Xixia [P/S]
   (S4) MR TABS, A39/20.1.1/0619  Prim.syphil: 2-4 g dly.for 10-15 days.   Azithromycin.
   707761-001: 500 mg, 5, R101,19  Legionnair.dis: 0,5-1 g 4x dly.  Indications: Adults & childr.1 yr.& over: U&LRT, suscept.un-
   707761-002: 500 mg, 10, R202,38  (S4) SUSP, [P/S] L/20.1.1/148, 149  complic.skin & soft tiss. infects., uncomplic.genit.chlamydia tra-
   Dosage: Admin. with meals    758396-007: 125 mg/5 ml, 100 ml, R21,32  chomat. infects.
   Adults: 500 mg dly. Sev.infects: 2x500 mg dly.  758418-019: 250 mg/5 ml, 100 ml, R53,06  Childr.1 yr.& over: Suscept.pharyngit./tonsillit. & otit. media
   H.pylori eradicat: 2x500 mg dly.in combinat. with appropr antibiot   Dosage: Admin.bef.meals. Adults: 250-500 mg 6 hrly. Childr: 30-  (S4) TABS, A38/20.1.1/0693
   & acid low.agent x7-10 days. Safety & effic.with proton-pump inhibit.   50 mg/kg bm dly.in div.dos. May be doubl.in sev.infects.  705975-001: 500 mg, 3, R110,60
   other than  omeprazole not est.  Contraindications: Imp.liv.funct./jaund.or other liv.toxic.sympts.  Dosage: Tabs.not suit.for childr.und.45 kgs.
   HIV pts.with atypic.Mycobact.infects: 2x500 mg dly. Cont.as   with prev.erythromyc.treatm., ac. porphyr.  Adults & childr.over 45 kg: 500 mg once dly x3 days. Dos.regime
   long as clinic.& microbiologic. benef.demonstrat. Decr.effic.noted if   over 5 days: 500 mg on day 1, then 250 mg dly.on days 2-5.
   treatm. exceeds 12 wks.      Side effects: Comm: GI disturbs., N&V, diarrh. Superinfect., poss.  Chlamyd.trachomat: Adults: 1 g as sngl.dos.
                                pseudomembr.colit., allerg. reacts., cholestat.hepatit., revers.deafn.
   Contraindications: Concom.astemizole, cisapride /pimozide &
   terfenadine ther., porphyr., safety in pregn.& lactat.not est., safety   aft.high dos.  Contra-indications: Sens.to macrolide antibiot., concom.ergot.
                                                              derivat., liv.funct. impairm., safety & effic.in pregn./lactat.& childr.
   & effic.in infts. und.6 mnths not est.  Warnings and special precautions: Safety in pregn.& lactat.
   Side effects: Leukopen., thrombocytopen., hypoglycaem., CNS eff.  not est., childr., diab.mellit., Tabs: lact. intol. Susp: Contains su-  und.1 yr not est.
   incl.convuls.& psychos., QT prolongat./ ventricul.tachycard.& torsades   crose & sorbitol.  Side-effects: Neutropen., palpit.& arrythm.incl. ventric.tachycard.,
   de pointes, GI disturbs., hepat.dysfunct., skin reacts. incl.Stev.John-  Interactions: Effs.of carbamazepine/corticoster. & digox. poss.po-  chest pain, CNS effs., hear. loss., convuls., asthen., parathes., GI dis-
   son syndr.& tox.epiderm. necrolysis, allerg.reacts.incl.anaphylax.  tent., potent. tox.theophyll.conc., warfar. eff. poss.enhanc., avoid con-  turbs., malaena, interstit.nephrit., ac.ren.fail., vaginit., trans. elev.liv.en-
   Special precautions: Imp.hepat./sev.ren.funct., rhabdomyolysis re-  com.lincomycin & chloramphen.as antagon.occurs, poss.false rais.   zymes, cholestat.jaund., hepatit., erythema multiforme, Stev.-Johnson
   port with HMGCoA reduct. inhibit., incr.incid.of uveitis when rifabutin   transamin.lev., interfer.with fluorimetr.estimat./ urin. catecholamin.  syndr., tox. epiderm.necrolys., allerg.reacts.incl.anaphylax., superinfect.
   & rifampicin co-admin. compar.to rifabutin alone, monit. theophyll.  ROXXIBID, Cipla Medpro [P/S]  Special precautions: Ren.funct.impairm., prolong. observat.&
   ser.conc., cross resist.report. with other macrolides/lincomycin &   Roxithromycin.  symptomat.treatm.of allerg. reacts.as sympt.have recurr.despite
   clindamycin, max. 1 g/day when admin.concurr.with ritonavir, other   Indications: Mild to mod.infect.caus by suscept. organism.  discont., poss. pseudomembr.colit., admin.1 hr.bef.or 2 hrs. aft.
   HIV protease inhibit.& non-nucleoside reverse transcriptase inhibit.,   antacids.,monit.prothromb.time with concom. warfar.
   safety & effic.in combinat. with proton-pump inhibit.other than ome-  (S4) TABS. 37/20.1.1/0367  Drug interactions: Antacids decr.peak ser. conc., ac.ergot.toxic.
                                704782-001: 150 mg, 10, R108,85
   prazole not est., excret.in human breast milk., pseudomembr.colit.,   with ergot alkaloids, ser. digox. & terfenadine conc.poss.incr., ser.
   discont.if signs of hepat. dysfunct.develop,  Dosage: 150 mg 12 hrly.bef.meals. Admin.for min of 10 days in ß-  lev.of meds. metabol. by cytochrome P450 enzyme syst. poss. incr.,
                                haemolyt. streptococc.infects.
   Drug interactions: QT-prolong.& card.arrhythm. incl.torsades de   theophyll.area und.plasma curve poss. incr.
   pointes with terfenadine, astemizole, cisapride, & pimozide, effs.of   Contraindications: Concom.vasoconstrict.ergot deriv., other mac-  ZITHROLIDE, (Activo) LeBasi [P/S]
   anticoags. potent., digox.ser.conc.incr., poss. elev. ser.lev.of meds.  rolide hypersens., concom. astemizole/ terfenadine/pimozide &   Azithromycin.(as dihydrate)
   metabol.by the cytochrome P450 syst., rifabutin & rifampicin decr.  cisapride, safety in pregn.& lactat.not.est.  Indications: Mild-mod.LRTI incl.bronchit.& pneumon., uncomplic.
   ser.conc., incr.lev. of circulat.theophylline, zidovudine ser.conc.decr.,   Side effects: Bld disords., hypersens.reacts., dizzin., headache,   skin & soft tiss., sinusit., altern. to first line pharyngit./tonsillit.ther.
   metabol.inhibit.by ritonavir.  paraesthes., card.arrhythm., GI disturbs., hepatobil.disords., taste
                                & /smell disords.             by suscept. organ., uncomplic.genit.chlamyd.infects. &/ gonorrh.
   KLARIZON, Biotech [P/S]      Special precautions: Hepat./ren.insuffic., elderly., arrhythm.&   in sex.transmitt.dis.
   Clarithromycin.              prolong.QT interv.hist., concom. warfar./digox., ECG monit.with dis-  Childr.over 45 kg: Suscept.pharyngit./tonsillit.& otit.media.
   Indications: L & URTI , skin & soft tiss.infects., H.pylori eradicat.  opyramide, superinfect.  (S4)  TABS, 45/20.1.1/0969, 0970
   decr.recurr.of duod.ulc.in combinat. with a proton-pump inhibit.&   Drug interactions: Poss.theophylline /digox. toxic., disopyramide   721676-001: 250 mg, 6, R109,73
   another antibiot.            free serum lev.poss.rais., sev. card.effs.with concom.astemizole/   721677-001: 500 mg, 3, R109,73
   (S4) TABS, 38/20.1.1/0724, 0725  terfenadine/ pimozide & cisapride, prolong.& incr effs.of mida-  Dosage: Tabs.not suit.for childr.und.45 kgs.
   707255-001: 250 mg, 10, R101,33  zolam, warfar.incr prothromb.time/ INR, ser. conc.of cyclospor.&   Adults & childr.over 45 kg (all indicat. excl. STD): 500 mg
   707256-001: 500 mg, 10, R82,06  lovastatin incr.           once dly x3 days.
   707256-002: 500 mg, 14, R114,89                            STDs: Adults: 1 g as sngl.dos.
   Dosage: Adults: 250 mg 2xdly. Sev.infect.dos. poss.incr.to   SANDOZ-AZITHROMYCIN 500, Sandoz [P/S]  Contraindications: Sens.to macrolide antibiot., concom.ergot.de-
   500 mg 2xdly.                Azithromycin monohydr.equiv.to azithromycin  rivat., liv.funct.impairm.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page272.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page268.html">268</a>&nbsp;&nbsp;&nbsp;<a href="page269.html">269</a>&nbsp;&nbsp;&nbsp;<a href="page270.html">270</a>&nbsp;&nbsp;&nbsp;<a href="page271.html">271</a>&nbsp;&nbsp;&nbsp;<a href="page272.html">272</a>&nbsp;&nbsp;&nbsp;<a href="page273.html">273</a>&nbsp;&nbsp;&nbsp;<a href="page274.html">274</a>&nbsp;&nbsp;&nbsp;<a href="page275.html">275</a>&nbsp;&nbsp;&nbsp;<a href="page276.html">276</a>&nbsp;&nbsp;&nbsp;<a href="page277.html">277</a>&nbsp;&nbsp;&nbsp;<a href="page278.html">278</a>
             </td>
             <td width="35%"><a href="page274.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page274.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
